ARCHIVES

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

This article is from The Cancer Letter archive.

Vol. 19 No. 12 | March 19, 1993

Download PDF Visit The Full Archive

Related Articles

Celgene Signs CRADA With NCI For Development Of CDC-501.

June 30, 2000

Abraxane Improves Progression-Free Survival Compared to Decarbazine In Stage IV Disease

November 30, 2012

Colorectal Cancer Screening Practices Need Improvement, CDC Practice Study Finds

April 30, 2010

Clinical Trials Approved By NCI CTEP During May

June 28, 2002

Campath Improves PFS In B-Cell CLL In Phase III Trial

January 26, 2007

In Congress: Bills Seek Medicare Coverage for Patients In Cancer Clinical Trials

April 23, 1999